Inventor
Nisthal Alex
US19 patents
⚠️ This page may combine multiple inventors who share the name “Nisthal Alex”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XENCOR INC
17 patentsUS10787518B2Sep 29, 2020
Bispecific checkpoint inhibitor antibodies
XENCOR INC15 citations94
US11472890B2Oct 18, 2022
Heterodimeric antibodies that bind ENPP3 and CD3
XENCOR INC9 citations84
US10982006B2Apr 20, 2021
Heterodimeric antibodies that bind fibroblast activation protein
XENCOR INC8 citations84
US11618776B2Apr 4, 2023
Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domains
XENCOR INC4 citations75
US11236170B2Feb 1, 2022
Bispecific checkpoint inhibitor antibodies
XENCOR INC1 citations73
US11919956B2Mar 5, 2024
Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3
XENCOR INC4 citations72
US12448423B2Oct 21, 2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains
XENCOR INC0 citations62
US12378313B2Aug 5, 2025
Bispecific binding agents binding to CLDN18.2 and CD3
XENCOR INC0 citations62
US12180302B2Dec 31, 2024
Heterodimeric antibodies that bind fibroblast activation protein
XENCOR INC0 citations62
US12152076B2Nov 26, 2024
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
XENCOR INC0 citations62
US12006345B2Jun 11, 2024
Untargeted and targeted IL-10 Fc-fusion proteins
XENCOR INC0 citations62
US11312770B2Apr 26, 2022
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
XENCOR INC1 citations62
US12398207B2Aug 26, 2025
Heterodimeric antibodies that bind CD3 and CLDN6
XENCOR INC1 citations61
US11492407B2Nov 8, 2022
Bispecific checkpoint inhibitor antibodies
XENCOR INC0 citations61
US12404329B2Sep 2, 2025
Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3
XENCOR INC0 citations60
US11859012B2Jan 2, 2024
Heterodimeric antibodies that bind CD3 and GPC3
XENCOR INC0 citations60
US11739144B2Aug 29, 2023
Heterodimeric antibodies that bind CD3 and CLDN6
XENCOR INC0 citations59